メリーランド州における大うつ病性障害の臨床試験
メリーランド州内の拠点で、大うつ病性障害に関する21件の研究が参加者を募集しています。
メリーランド州内の都市
公式研究テキスト（英語）
NIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar Disorder
- National Institutes of Health Clinical Center, Bethesda
被験者募集中観察研究健康なボランティア歓迎
8歳〜70歳 · 全性別 · 2026/10/02更新 · NCT05669703Natural History of Depression, Bipolar Disorder and Suicide Risk
- National Institutes of Health Clinical Center, Bethesda
被験者募集中観察研究
18歳〜120歳 · 全性別 · 2026/10/01更新 · NCT06462196A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Pharmasite Research, Inc., Baltimore
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/10/01更新 · NCT07775300A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Pharmasite Research, Inc., Baltimore
被験者募集中第3相
18歳〜74歳 · 全性別 · 2026/10/01更新 · NCT07573176Characterization and Treatment of Adolescent Depression
- National Institutes of Health Clinical Center, Bethesda
被験者募集中観察研究健康なボランティア歓迎
11歳〜25歳 · 全性別 · 2026/09/28更新 · NCT03388606A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- Delricht Research - Rockville, Rockville
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07621237A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
- Johns Hopkins University, Baltimore
被験者募集中第3相
12歳〜17歳 · 全性別 · 2026/09/25更新 · NCT07227454A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Sunstone Medical, PC, Rockville
被験者募集中第3相
18歳〜85歳 · 全性別 · 2026/09/25更新 · NCT06793397Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
- National Institutes of Health Clinical Center, Bethesda
被験者募集中第1相健康なボランティア歓迎
18歳〜65歳 · 全性別 · 2026/09/22更新 · NCT03065335Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders
- National Institutes of Health Clinical Center, Bethesda
- University of Maryland, College Park, College Park
被験者募集中第2相健康なボランティア歓迎
8歳〜65歳 · 全性別 · 2026/09/22更新 · NCT00018057Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression
- National Institutes of Health Clinical Center, Bethesda
被験者募集中第2相
18歳〜70歳 · 全性別 · 2026/09/14更新 · NCT06511908Defining Neurobiological Links Between Substance Use and Mental Illness
- National Institute on Drug Abuse, Baltimore
被験者募集中健康なボランティア歓迎
18歳〜60歳 · 全性別 · 2026/09/11更新 · NCT05538910Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression
- National Institutes of Health Clinical Center, Bethesda
被験者募集中第1相
18歳〜70歳 · 全性別 · 2026/09/10更新 · NCT03973268Neurobiology of Suicide
- National Institutes of Health Clinical Center, Bethesda
被験者募集中第2相健康なボランティア歓迎
18歳〜70歳 · 全性別 · 2026/09/09更新 · NCT02543983A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Pharmasite Research Inc., Baltimore
被験者募集中第3相
18歳〜74歳 · 全性別 · 2026/09/08更新 · NCT07076407A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Gaithersburg
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/08/26更新 · NCT07300969A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Pharmasite Research, Inc., Baltimore
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/08/06更新 · NCT07412756A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Continental Clinical Solutions, Towson
被験者募集中第2相
18歳〜64歳 · 全性別 · 2026/07/27更新 · NCT07115329Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Gaithersburg
被験者募集中第3相
18歳以上 · 全性別 · 2026/07/24更新 · NCT06966401Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Clinical Research Site, Pikesville
被験者募集中第3相
18歳〜65歳 · 全性別 · 2026/07/24更新 · NCT07484217A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Sheppard Pratt, Baltimore
- Sunstone Medical, PC, Rockville
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/05/11更新 · NCT06524830ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。